NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-022-2017-0-US-10 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US CON 17/703,005 Abandoned
NEI E-227-2018-0-AU-03 Druggable Taraget to Treat Retinal Degeneration AU National Stage 2020346064 Pending
NIDDK E-086-2022-0-US-01 METHOD AND SYSTEM FOR SYNCHRONIZING A ROTATIONAL ECCENTRIC MASS WITH A MAGNETIC RESONANCE ELASTOGRAPHY SCAN US ORD 17/702,212 11821972 Issued PDF
NIDDK E-138-2017-0-CN-19 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CN DIV 202210281874.3 Pending
NCATS E-041-2021-1-US-01 RALDH1 Inhibitors For The Immunotherapy Of Hepatocellular Carcinoma US 63/321,682 Expired
NCI E-030-2022-0-AU-01 Anti-Viral Compositions And Methods Of Making And Using AU National Stage 2020346819 Pending
NIDDK E-001-2022-0-US-01 MOTOR FOR A MR ELASTOGRAPHY TRANSDUCER US ORD 17/697,492 11852704 Issued PDF
NCI E-097-2021-0-PCT-02 FLUOROGENIC CYANINE CARBAMATES PCT PCT PCT/US2022/020708 Expired
NIAID E-081-2013-4-JP-21 Prefusion RSV F Proteins And Their Use JP DIV 2022-041006 Issued
NCI E-042-2014-0-US-33 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US CON 17/696,249 Pending
NCATS E-039-2021-0-PCT-02 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION PCT PCT PCT/US22/20596 Expired
NCI E-176-2022-0-CA-01 Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease CA National Stage 3154761 Pending
NEI E-227-2018-0-ZA-14 Druggable Target to Treat Retinal Degeneration ZA National Stage 2022/03100 Pending
NCI E-111-2021-0-PCT-02 CANCER VACCINE AND METHOD OF USE THEREOF PCT PCT PCT/US2022/020165 Expired
NIAAA E-189-2021-0-US-01 CANNABINOID RECEPTOR MODULATING COMPOUNDS US 63/319,642 Expired
NCI E-042-2014-0-IL-34 Chimeric Antigen Receptors Targeting CD-19 IL DIV 1992-12-29 Pending
NEI E-227-2018-0-US-13 DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION US National Stage 17/642,610 Pending
NCI E-181-2017-0-US-23 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US DIV 17/692,787 Pending
NCI E-182-2019-2-US-07 RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US National Stage 17/692,978 Pending
NIAID E-029-2007-0-US-05 RECOMBINANT VIRUS WITH DIMINISHED LATENCY AND METHODS OF USING SAME US DIV 17/692,540 Pending
NEI E-227-2018-0-BR-04 Druggable Taraget to Treat Retinal Degeneration BR National Stage BR112022004515-8 Pending
NEI E-227-2018-0-MX-12 Druggable Taraget to Treat Retinal Degeneration MX National Stage MX/a/2022/003027 Pending
NEI E-227-2018-0-JP-10 Druggable Taraget to Treat Retinal Degeneration JP National Stage 2022-516237 Pending
NCI E-075-2022-0-US-01 ANTIBODY MATERIALS AND METHODS TARGETING MICROBIAL POLYSACCHARIDES US 63/319,090 Expired
NEI E-227-2018-0-CA-05 Druggable Taraget to Treat Retinal Degeneration CA National Stage 3151011 Pending
NCI E-266-2011-0-US-61 T CELL RECEPTORS RECOGNIZING HLA-A1-RESTRICTED MAGE-A3 US CON 17/691,569 Pending
NCI E-030-2022-0-CA-01 Anti-Viral Compositions And Methods Of Making And Using CA National Stage 3150731 Pending
NHLBI E-106-2022-0-US-01 Method And System For Concomitant (Maxwell) Field Compensation For 2D Spiral-Ring Turbo Spin-Echo Imaging US 63/318,156 Expired
NCI E-030-2022-0-US-02 Anti-Viral Compositions And Methods Of Making And Using US National Stage 17/641,264 Pending
NCI E-133-2016-0-US-10 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME US CON 17/689,698 Pending
NIAID E-257-2015-0-US-04 COMPOUNDS FOR MODULATING FC-EPSILON-RI-BETA EXPRESSION AND USES THEREOF US DIV 17/688,618 Abandoned
NHLBI E-121-2016-2-US-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE US DIV 17/688,435 Pending
NCI E-074-2022-0-US-01 INTEGRASE STRAND TRANSFER INHIBITORS US 63/317,327 Expired
NIDDK E-043-2020-0-EP-01 RNA Target Enrichment or Depletion of Biological Supplies EP National Stage 21763708.1 Pending
NIDDK E-043-2020-0-JP-01 RNA Target Enrichment or Depletion of Biological Supplies JP National Stage 2022-553079 Pending
NICHD E-058-2021-0-PCT-02 La Protein As A Novel Regulator Of Osteoclastogenesis PCT PCT PCT/US2022/018639 Expired
NIDA E-053-2016-1-US-32 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF US DIV 17/685,709 Pending
NIDDK E-110-2021-0-US-01 SYNTHETIC AMPHIPATHIC HELICAL PEPTIDES AND TREATMENT METHODS USING SYNTHETIC AMPHIP ATHIC HELICAL PEPTIDES US 63/316,113 Expired
NIAID E-050-2022-0-US-01 MONOCLONAL ANTIBODIES TO NIPAH VIRUS F PROTEIN AND THEIR USE US 63/315,934 Expired
NIAID E-216-2014-0-JP-16 RECOMBINANT RS VIRUS STRAINS WITH MUTATIONS IN M2-2 ORF PROVIDING RANGE OF ATTENUATION PHENOTYPE JP DIV 2022-030778 Issued
NIDA E-057-2021-0-PCT-02 DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF PCT PCT PCT/US2022/018287 Expired
NCATS E-101-2017-0-US-06 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS US DIV 17/682,654 11795177 Issued PDF
NCI E-296-2011-0-US-07 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY US DIV 17/682,655 Abandoned
NCI E-230-2012-0-KR-69 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 KR DIV 10-2022-7006700 Issued
NIAID E-048-2020-0-US-03 COMPOSITIONS INCLUDING IGG Fe MUTATIONS AND USES THEREOF US National Stage 17/638,139 Pending
NCATS E-072-2021-0-PCT-02 FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE PCT PCT PCT/US2022/017248 Expired
NCI E-040-2012-0-KR-69 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2022-7005825 Pending
NIAID E-045-2021-0-PCT-02 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE PCT PCT PCT/US2022/070744 Expired
NIAMS E-244-2020-0-PCT-02 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 PCT PCT PCT/US2022/016986 Expired
NIAMS E-244-2020-0-US-02 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 US National Stage 18/546,933 Issued